Granulated Sugar Market 2022 by Global Key Players, Types, Applications, Countries, Industry Size and Forecast to 2029

Granulated sugar is a rich source of carbohydrates which soluble in nature. The sugar is made up of various sources like sugarcane, sugar beet, date palm, sorghum, and sugar maple, etc. For the production of sugar, sugarcane is widely used as a raw material across the globe. The industrial sugar is classified into powdered, granulated and syrup on the basis of product. The granulated sugar is also known as white sugar. Granulated sugar is used in the food & beverage industry, bakery and confectionery; it is a primary ingredient in the food & beverage industry. The demand for food applications is increasing rapidly all over the world which is growing demand for granulated sugar market. The number of players participating in granulated sugar industry is increasing. The increasing demand for granulated sugar and a growing number of manufacturers all over the world are the reasons for increasing the competitive level in the market. To save the position in granulated sugar market manufacturers are producing unique & innovative products in the market with attractive offerings.

Request a sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-9789

Increasing Demand In Food & Beverage Industry Is The Main Reason For Phenylalanine Market Growth:

Granulated sugar is used widely in bakery products like cookies, biscuits, cakes, pastry, muffins, jams, marmalades, etc.  Granulated sugar is used in ice creams as well as chocolates. The chocolates and all bakery products are favorite amongst the children as well as old individuals. The sale of ice cream is increasing in the summer season. Granulated Sugar is a primary ingredient in these food items, without sugar it cannot be prepared. The demand for bakery products, chocolates, and ice creams are increasing rapidly and the production of these food items is forecasted to increase in the future. This helps to boost the demand for granulated sugar market. Granulated sugar is used in the beverage industry. Granulated sugar is used in alcoholic as well as non-alcoholic beverages. It is used for adding sweet taste and aroma in the beverage industry

The consumption of beverages is increasing which is growing the demand of granulated sugar market. As granulated sugar is one of the main ingredients in the food & beverage industry, the demand for the sources from which granulated sugar is prepared is also increasing. The demand for sugarcane crop is increasing so farmers are getting a good price for sugarcane crop in the market which is helping to increase per capita income.

Some individuals follow a strict diet for losing weight and those individuals avoid sugar intake because of which they suffer from the anemic condition, deficiency of vitamins and minerals as sugar is a rich source of energy and carbohydrates.  Granulated sugar is used as a sweetener in tablets and syrups. The demand for tablets and syrups is increasing rapidly because of which granulated sugar is used in the pharmaceuticals industry widely which is boosting the growth of granulated sugar market. The increasing awareness about healthy lifestyle and nutritional food habits can affect the granulated sugar market. Sugar high amount of fats and calories which can affect the sale of granulated market.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-9789

Granulated Sugar Market: Regional Analysis:

Asia-Pacific is leading in the production of granulated sugar and it is expected to increase the production and plantation of sugarcane in the forecasted period. In Asia-Pacific mainly India, China, Indonesia are the producers of granulated sugar. Europe is dominating the production of beet sugar. The North-America is also expected to increase the production of granulated sugar in the near future

 Granulated Sugar Market: Key Participants: 

  • Sudzucker
  • C&H Sugar
  • Lotus Health Group
  • Ganzhiyuan
  • Archer Daniels Midland Company
  • Nordzucker Group AG
  • Wilmar International Ltd
  • Illovo Sugar Ltd
  • Cargill
  • Wholesome Sweeteners
  • Nordic Sugar A/S
  • D Parry Limited
  • Wilmar International Ltd
  • Mitr Phol Sugar Corp
  • Nordzucker Group AG, Cosan SA
  • Suedzucker AG

The research report presents a comprehensive assessment of the granulated sugar market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as product type, application, and end use.

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/9789

On the basis of source, the granulated sugar market is segmented into:

  • Sugarcane
  • Sugar beet
  • Date palm
  • Sorghum
  • Sugar maple
  • Others

On the basis of product, the granulated sugar market is segmented into:

  • Soft sugar
  • Crystal sugar
  • Others

On the basis of end use, the granulated sugar market is segmented into:

  • Bakery Industry
  • Beverage Industry
  • Confectionery & Ice-Cream Industry
  • Pharmaceutical Industry
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing dynamics of the granulated sugar market in the industry
  • In-depth market segmentation and analysis
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments in granulated sugar market
  • Competitive landscape of the granulated sugar market
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective granulated sugar market performance
  • Must-have information for granulated sugar market players to sustain and enhance their market footprint.

Nutrigenomic Market 2022 by Global Key Players, Types, Applications, Countries, Industry Size and Forecast to 2029

Nutrigenomics is a novel technology that is designed to build the gap between nutrition and advanced genetics. Nutrigenomics is a tool that is developed for medical professionals to understand the consumer’s metabolic needs and then recommend the nutritional supplements accordingly. Nutrigenomics allows a personalized nutritional recommendation for an individual. Nutrigenomics focuses on Single Nucleotide Polymorphisms (SNPs) that account for 90% of the variation in the human genome. Nutrigenomics uses tools such as biomarkers, clinical data, and genomic assays. Nutrigenomics helps to identify the chances of occurrence of a disease and enables to get personalized treatment for it. Nutrigenomics has applications in hospitals, research organizations, dietary supplement industry, pharmaceutical industry, etc.

Request a sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-9787

Increasing Demand for Personalized Products is Propelling the Nutrigenomics Market

The increase in the prevalence of diabetes, other chronic diseases is anticipated to increase the demand for nutrigenomics. According to the World Health Organization, in 2016, approximately 1.6 million deaths occurred due to diabetes and was the seventh leading cause of death in the world. Chronic diseases are the major cause of death all across the globe. By 2020, the chronic diseases are anticipated to rise up to 73% of the total deaths. The most common chronic diseases are cardiovascular diseases, cancer, and diabetes. As the health-awareness is increasing, the consumers are willing to pay more so as to live a healthy lifestyle. The demand for personalized products is anticipated to increase to reduce the risk of diseases and disorders. The demand for personalized products is anticipated to boosts the demand for nutrigenomics.

Also, the number of obese and overweight population is increasing at a high rate. According to the WHO, in 2016, more than 340 million children of age ranging from five to nineteen were obese or overweight. The global prevalence of obesity has almost tripled from 1975 to 2016. The increase in weight management issues is anticipated to increase the demand for weight loss supplements and medicines. Thus, the manufacturers in pharmaceutical and dietary supplement industries are anticipated to opt for nutrigenomics to study the metabolic profile of the patients and to provide the solutions accordingly.

In recent years, the companies are trying to use nutrigenomics to optimize the nutrition intake that would help in reducing the chances of diseases at all stages of life. The increasing demand for healthy personalized products is expected to increase the inclination of food manufacturers towards the use of nutrigenomics so as to formulate personalized products, which is estimated to increase the demand for nutrigenomics in the food industry.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-9787

Nutrigenomics Market: Regional Analysis

The demand for nutrigenomics is estimated to grow at a high rate in the North America region. According to the Centers for Disease Control and Prevention (CDC), by 2030, around 42% of the population in America is estimated to suffer from obesity. As the awareness about obesity increases, the consumer inclination towards the use of personalized products is projected to increase. Thus, the increase in the number of obesity is expected to serve as a major driver for the increase in the demand for nutrigenomics in the North America region.

Asia Pacific region also creates an excellent opportunity for the companies that provide nutrigenomics service. The increase in the prevalence of diabetes and obesity are anticipated to serve as a major driver for the increase in the demand for nutrigenomics. According to the WHO, by 2030, the occurrence of diabetes in India is anticipated to reach around 79 million. Malaysia has a huge problem of obesity and tops the list for the highest prevalence of diabetes and obesity in the South-East Asia region. Thus, the increasing cases of diabetes and obesity are estimated to have a positive impact on the nutrigenomics market.

Nutrigenomics Market: Key Participants

Some of the key market players in the nutrigenomics market are:

  • GX Sciences, Inc
  • Nutrigenomix
  • NutraGene
  • Cura Integrative Medicine
  • Metagenics, Inc
  • XCODE Life Sciences Pvt. Ltd.
  • Nutrigenomics New Zealand
  • Ora Organic

The research report presents a comprehensive assessment of the nutrigenomics market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as end-use.

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/9787

The report covers exhaustive analysis on:

  • Nutrigenomics Market Segments
  • Market Dynamics
  • Market Size
  • Supply and Demand
  • Current Trends/Issues/Challenges pertaining to nutrigenomics market
  • Competition Landscape and Emerging Market Participants in nutrigenomics market
  • Technology related to Production/Processing of nutrigenomics
  • Value Chain Analysis of the nutrigenomics market

Nutrigenomics Market Segmentation

The nutrigenomics market can be segmented on the basis of end-use-

On the basis of end-use, the nutrigenomics market can be segmented as:

  • Food and Beverage
  • Pharmaceutical
  • Functional Foods and Dietary Supplement
  • Hospitals
  • Academic and Research Organizations

Report Highlights:

  • Detailed overview of parent market
  • Changing dynamics of the nutrigenomics market in the industry
  • In-depth market segmentation and analysis
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments in the nutrigenomics market
  • Competitive landscape of the nutrigenomics market
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on nutrigenomics market performance
  • Must-have information for nutrigenomics market players to sustain and enhance their market footprint

Liquid Biopsy Market Prospects and Growth Assessment 2031

As per a recent market survey by ESOMAR-certified consulting firm Future Market Insights (FMI), the global liquid biopsy market is expected to reach a market valuation of US$ 1,026 Mn in 2021.

With the introduction of innovative molecular diagnostic tests and growing demand from biotech and pharmaceutical companies, the market is poised to expand at a stellar 13.49% CAGR, reaching US$ 3,637 Mn by 2031.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-1396

Growth of the liquid biopsy market is attributable to rising incidence of cancer across several countries, which is highlighting the pressing need for faster, simpler, and more convenient diagnostic procedures. Liquid biopsy procedures are minimally invasive and cost-effective, which is making them a favorable choice for cancer diagnosis procedures.

Besides this, increasing government-backed initiatives to support cancer research across the U.S., Japan, India and the UK will drive innovation and developments in liquid biopsy services. Also,  fast track approval from regulatory bodies for novel procedures will bolster the growth over the coming years.

Additionally, technological advancements such as the incorporation of machine learning and microchip-based liquid biopsy systems will further strengthen growth prospects in the market.

As per the market survey, counties including the U.S., the U.K, and Japan will be at the forefront of innovation and adoption of liquid biopsy services, owing to the presence of leading players and prevalence of numerous high-potential cancer research institutes.

Germany, India, and China will emerge as high growth potential markets, with increasing investments by the government for improving the healthcare infrastructure, which will create attractive opportunities to global biotech players for market expansion.

“Increasing incidence of cancer, coupled with incorporation of latest technology in liquid biopsy for faster and more convenient diagnosis will continue to augment the market growth throughout the forecast period,” says the FMI analyst.

Key Takeaways from the Liquid Biopsy Market Analysis

  • Based on markers, circular tumor cells (CTC) are poised to emerge dominant in the forthcoming years.
  • Blood samples will emerge as the most preferred sample type
  • In terms of applications, liquid biopsy will be widely preferred for lung cancer diagnosis.
  • Cancer institutes are expected to remain dominant end users, accounting for over 40% of the total revenue share.
  • The U.S. will showcase high growth during the forecast period, due to the presence of major liquid biopsy product manufacturers.
  • The U.K. will emerge as an avenue for product innovations and development, further solidifying growth prospects.
  • Japan is anticipated to witness upswings in sales, owing to government-led cancer research initiatives.
  • India is expected to showcase high demand for liquid biopsy products, owing to the increased funding by government and expansion of healthcare infrastructure.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-1396

Competitive Landscape

BIOCEPT, INC., Qiagen N.V., Trovagene, Inc, Janssen Global Services, LLC, MDxHealth SA, Natera, Inc, F. Hoffmann-La Roche Ltd, Silicon Biosystems, Pathway Genomics Corporation, and Sysmex Corporation are among top manufacturers of liquid biopsy products, as profiled by FMI. As per the market survey, tier-1 companies are anticipated to account for approximately 20-25% of the total market share.

Strategic collaborations, partnerships, and product innovations are some of the prominent growth strategies applied by leading market players to establish a strong foothold in the liquid biopsy market. For instance:

  • In June 2021, Biocept Inc., collaborated with Quest Diagnostics, a New Jersey-based clinical laboratory, to offer laboratory services to Quest patients for its Target Selector NGS-based liquid biopsy lung cancer panel.
  • In February 2021, Menarini Silicon Biosystems, a leading developer of liquid biopsy and single-cell technologies, launched its innovative CellMag product line for staining and detection of rare circulating tumor cells (CTCs).

Peptide Receptor Radionuclide Therapy (PRRT) Market to Garner Brimming Revenues by 2029

This Peptide Receptor Radionuclide Therapy Prrt market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Peptide Receptor Radionuclide Therapy Prrt market.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-10376

Advancement and growing researches in the medical industry leads to a dramatic surge in the availability of new cancer treatment options. Radiation therapies and targeted therapy is showing significant promise in cancer treatment. For example, peptide receptor radionuclide therapy (PRRT) had recently approved the neuroendocrine tumors and projecting significant growth in the cancer treatment market. Peptide receptor radionuclide therapy (PRRT) is radioisotope or molecular therapy used to treat neuroendocrine tumors (NETs). Peptide receptor radionuclide therapy (PRRT) is recommended for the somatostatin receptor-positive gastroenteropancreatic NETs affected patients. Peptide receptor radionuclide therapy (PRRT) is a targeted therapy designed to slow the progression of gastroenteropancreatic NET and limiting radiation exposure to healthy tissue.

Lutathera (lutetium Lu 177 Oxodotreotide) was the first drug approved for the peptide receptor radionuclide therapy (PRRT) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). In September 2017, the European Commission approved Lutathera peptide receptor radionuclide therapy (PRRT) drug manufactured by Advanced Accelerator Applications S.A. Although, the U.S. Food and Drug Administration (FDA) was approved LUTATHERA in January 2018. Growing clinical trials and development activities to create therapeutic radiopharmaceuticals expected to surge the growth of the peptide receptor radionuclide therapy (PRRT) market over the forecast period.

Peptide Receptor Radionuclide Therapy (PRRT) Market: Drivers and Restraints-

Increasing prevalence of the neuroendocrine tumors expected to impel the demand for peptide receptor radionuclide therapy (PRRT) as an increasing number of the patient pool. Establishment of reimbursement policies for Lutathera favors the demand for peptide receptor radionuclide therapy (PRRT). A temporary insurance/billing code was used for the peptide receptor radionuclide therapy (PRRT) till 2018. Moreover, increasing clinical trials for the new radiopharmaceuticals drugs approval for cancer therapy expected to surge the growth of the peptide receptor radionuclide therapy (PRRT) market. Increasing government and private organizations funding for cancer drugs and therapy development is another major factor expected to propel the growth of the peptide receptor radionuclide therapy (PRRT) market. Moreover, growing manufacturer’s interest in the radiopharmaceutical and cancer market flourish the growth of the peptide receptor radionuclide therapy (PRRT) market. Side effects such as the transient decrease in blood counts, nausea and others associated with PRRT expected to hamper the growth of the peptide receptor radionuclide therapy (PRRT) market.

Peptide Receptor Radionuclide Therapy (PRRT) Market: Overview

Peptide receptor radionuclide therapy (PRRT) a special type of radiopharmaceutical which injected into the patients’ bloodstream. This radiopeptide travels and binds to neuroendocrine tumor cells and provide a high dose of radiation directly to the cancer cell. Big pharmaceutical market players are focusing to enter in the radiopharmaceutical market. For instance, In October 2017, Novartis AG acquired Advanced Accelerator Applications (AAA) for $3.9 billion to expand oncology portfolio. This acquisition was valuable for Lutathera radiopharmaceutical candidates which were under FDA review in 2018.

Peptide Receptor Radionuclide Therapy (PRRT) Market: Region-wise Outlook

North America and Europe region are expected to grebe more than half of the market share for peptide receptor radionuclide therapy. Increasing clinical trials for radiopharmaceuticals and growing demand for the targeted therapy for cancer are the major factors driving the growth of the peptide receptor radionuclide therapy market in the U.S. and European countries. The Asia pacific peptide receptor radionuclide therapy market expected to grow with significant growth rate as growing demand for advance treatment option and comparatively high prevalence of cancer in India and China.

Peptide Receptor Radionuclide Therapy (PRRT) Market: Key Market Participants

Example of some market players participants in global peptide receptor radionuclide therapy (PRRT) market find across the value chain are Advanced Accelerator Applications (AAA) (Novartis AG) and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, China ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-10376

Peptide Receptor Radionuclide Therapy (PRRT) Market: Segmentation

On the basis of indication, peptide receptor radionuclide therapy (PRRT) market can be segmented as:

  • Foregut Neuroendocrine Tumors
  • Midgut Neuroendocrine Tumors
  • Hindgut Neuroendocrine Tumors

On the basis of end user, peptide receptor radionuclide therapy (PRRT) market can be segmented as:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cancer Care Centers

Report highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Antimicrobial Peptides Market Estimated to Expand at a Robust CAGR By 2029

Antimicrobial Peptides are molecules that form part of host defense mechanism in prokaryotic as well as eukaryotic cells capable of protecting against the harmful infective threats modelled by the bacteria, viruses and even fungi.  The mode of action highly depends on the composition of antimicrobial peptides and hence utilized to target cytoplasmic membranes, cell walls, DNA and proteins. This makes antimicrobial peptides useful molecules to design assays, therapies and combination treatment via immunomodulation. The activation, elicitation and suppression of biological systems is gaining significant value in pharmaceutical as well as clinical applications to treat obscure oncological and rare maladies.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-10249

Antimicrobial Peptides Market: Drivers and Restraints

The cost of manufacturing antimicrobial peptides is more than the cost of manufacturing other pharmaceuticals for therapeutic utility depending on the target specificity. The business model for antimicrobial peptides is different than what is present in the pharmaceutical market owing to the novelty of the assays and techniques implemented.

The research process and designing the therapy process for commercialization is different, moreover the industry requires a more vigorous approach in order to create an entry and further access to the developing markets. Manufacturers of the antimicrobial peptides dependent therapy spend the majority their resources on upgrading the associated technology. The opportunities present in developing antimicrobial peptides are more as compared to threats prevalent. The application of antimicrobial peptides in ailment of Hepatitis C, pneumonia, bacterial infections, HIV AIDS and cancer is expected to surge the acceptance towards the therapies. The institutional research is heavily invested with rising pool of scientists and skilled technocrats interested in the domain for novel drugs involving antimicrobial peptides for rare diseases. The one of the pluses that include are antimicrobial peptides can be developed for a range of utilities ranging from increasing the shelf-life in food packaging to delivery of bioactive compounds in therapeutic sectors driving the market. The growing antibiotic resistance, synthetic approaches, innovative formulations and drug delivery routes are the factors expected to drive the growth.

Antimicrobial Peptides Market: Overview

The global market for antimicrobial peptides is estimated to experience a significant growth due to the increase in awareness and access towards drugs and therapies involving antimicrobial peptides. Chronic diseases where antibiotic resistance is not fruitful creates a more lucrative opportunity for manufactures present in the antimicrobial peptides market. The current structure of the antimicrobial peptides market include drugs targeted towards pneumonia, Hepatitis C, HIV and bacterial infections. Each of the antimicrobial peptides uses different type of mechanism and are used to deliver better clinical results.

Antimicrobial Peptides Market: Regional Outlook

Geographically, the Antimicrobial Peptides market is segmented into seven regions viz. South Asia, East Asia, Europe, Latin America, North America, Oceania and Middle East and Africa. Each country is equally important to drive the market for antimicrobial peptides, advanced or emerging healthcare settings help in restoring the market and increase the reach to a wider section of patients in need. The distribution channel is an important part for antimicrobial peptides; the developed markets focus on the applications wherein the antimicrobial resistance is compromised whereas the emerging markets are more focused towards the reach and affordability of antimicrobial peptides. The North America region is estimated to have a significant share in the antimicrobial peptides market, owing to its quality infrastructure supporting the need of antimicrobial peptides research activities undertaken. It is followed by Europe, East Asia and Oceania. The South Asia antimicrobial peptides market would translate as a lucrative market opportunity for manufacturers, as well as industry experts, with present change in adoption and growth in general pharmaceutical market.

The key players involved in the market of antimicrobial peptides market include Eli Lilly and Company, Pfizer Inc., GlaxoSmithKline plc, Novartis International AG, EnBiotix Inc., Johnson & Johnson Services, Merck & Co., Alexion Pharmaceuticals, Inc., Melinta Therapeutics, Inc., and Vertex Pharmaceuticals, Inc. The present market structure of antimicrobial peptides is expected to change with efforts and research present in clinical phase.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-10249

The report also maps the qualitative impact of various market factors on market segments and geographies.

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology Matrix
  • Value Chain

Regional analysis of the Antimicrobial Peptides market report includes

  • North America
  • Latin America
  • Europe
  • South  Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Antimicrobial Peptides Market: Segmentation

Tentatively, the global antimicrobial peptides market has been segmented on the basis of ailments, distribution channel, route of administration and geography.

Based on ailments, the antimicrobial peptides market is segmented as:

  • Pneumonia
  • Hepatitis
  • Bacterial infections
  • HIV

Based on distribution channel, the global antimicrobial peptides market is segmented as:

  • Hospital
  • Research Institutes
  • Specialty Clinic
  • Pharmacies

Based on rote of administration, the global antimicrobial peptides market is segmented as:

  • Topical
  • Subcutaneous
  • Intravenous

Antimicrobial Peptides Market Report Highlights:

  • Overview of Global Healthcare Market
  • Evolution of the technology
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Retinal Gene Therapy Market to Garner Brimming Revenues by 2029

This Retinal Gene Therapy market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Retinal Gene Therapy market.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-10246

Retinal gene therapy is performed for inherited retinal diseases. Gene therapy can improve the vision impairment caused by mutation in RPE65 gene.  The recently launched retinal gene therapy, Luxturna, is being used for patient with Leber congenital amaurosis type 2, it is a form of inherited disease which causes impaired vision at birth leading to a more progressive degeneration. There are many retinal gene therapy clinical trials present at the moment using recombinant viruses.

Retinal Gene Therapy Market: Drivers and Restraints

Retinal gene therapy is projected to grow at an enormous rate. Retina is a desirable target for gene therapy, it is growing because of it being an irreplaceable part of human body. Retinal gene therapy market is expected to experience new entrants, with promising candidates in clinical phases of drug approval.

The market is expanding exponentially over the last year, with many drugs in ongoing clinical trials. Currently, retinal gene therapy market have only one FDA approved product, Luxturna from Spark Therapeutics. The product received FDA approval in year 2017, starting an era of possible retinal gene therapy. Recently it was announced that Roche is interested in purchasing the company for approximately US$ 4.8 Bn, the interests from leading pharmaceutical manufacturers highlight the potential within this retinal gene therapy market. The market is influenced with a high prevalence of Stargardt disease, a common type of inherited retinal dystrophies, prevalence of around 1 in 12,000. Accurate and early diagnosis can lead to a better market structure, with patients willing to enrol in the clinical trials process. More number of approved products can lead to a more convenient reach for patients.

The availability of the approved therapy is also minimal in emerging economies, if available, emerging countries can be the most attractive segments in terms of value addition. Qualified surgeons and standard infrastructure is required for retinal gene therapy procedures, it involves a surgical and delivery plan with great precision. Socio-economic condition can lead to the late entry of such modality in emerging countries. But, if treatment is present for a previously stated incurable disorder, it should reach out to as many as possible. Cost associated with the retinal gene therapy is considerably high as observed in other gene therapy procedures. The cost of retinal gene therapy is estimated to be around US$ 450,000 to US$ 850,000 in the US

Retinal Gene Therapy Market: Overview

The global market for retinal gene therapy would expand with the emergence of new manufacturers and better technological advances. Retinal gene therapy is favoured to become the standard treatment, given the advantages with eye it has been at the forefront of translation research of gene therapy. The research initiatives for retinal gene therapy date back to the mid-1990s. The success of the very first retinal gene therapy will be replicated by other entrants, it just require a planned clinical trial platform for human testing to observe the level of expression achieved.

Retinal Gene Therapy Market: Regional Wise Outlook

Geographically, the retinal gene therapy market is segmented into seven regions viz. South Asia, East Asia, North America, Latin America, Oceania, Europe, and Middle East and Africa. The North America retinal gene therapy market is the leader in the concerned global retinal gene therapy market. The only product approved is from a US based manufacturer, which reflects to the current market share for North America. The retinal gene therapy is also available in Europe from Spark Therapeutics. The deal is such that Novartis has exclusive rights to commercialize and distribute “Luxturna” in Europe and in all other countries outside the US, when regularized for use. So, clearly the current market for retinal gene therapy is consolidated in these two region.

The only player involved in this market of retinal gene therapy is Spark Therapeutics, Inc. The present market structure of retinal gene therapy is expected to change with efforts and research present in clinical phase.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-10246

The report also maps the qualitative impact of various market factors on market segments and geographies.

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology Matrix
  • Value Chain

Regional analysis of the Retinal Gene Therapy market report includes

  • North America
  • Latin America
  • Europe
  • South  Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Retinal Gene Therapy Market: Segmentation

Tentatively, the global retinal gene therapy market has been segmented on the basis of product type, end user and geography.

Based on product type, the global retinal gene therapy market is segmented as

  • Voretigene Neparvovec

Based on end user, the global retinal gene therapy market is segmented as:

  • Hospitals
  • Specialty Clinics
  • Academic Research Institutes

Retinal Gene Therapy Market Report Highlights:

  • Overview of Global Healthcare Market
  • Evolution of the technology
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Veterinary Syringes Market Estimated to Expand at a Robust CAGR By 2029

Injection through syringes is the best method of administration drugs to the animals. Although the purpose of an injection is to benefit the animal, if proper technique is not used an injection has the potential to do harm. Adoption and selection of syringes helps in administration of life saving medicines, injury of animals and feed a hungry.

The veterinary syringes are driving the market due to its performance and increasing healthcare needs of veterinary animals. With improvements in the technologies Veterinary Syringes have become easy to use. Also they require less stress to animal keepers and provide accurate and quick results. Use of Veterinary Syringes help in managing various diseases by accurate dosing of the drugs. Also diet, exercise and regular veterinary checkups are important to improve the health of animals. With the rising adoption and increasing research & development and continuous efforts by the manufactures, the growth of Veterinary Syringes is expected to grow in the future.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-10238

Factors driving Veterinary Syringes Market

Veterinary Syringes are expected to drive the market with the increasing pet ownership and growing veterinary practices. According to the American Pet Products Manufactures Association (APPMA), United States holds 68% for pet ownership, which is expected to increase the market for veterinary syringes market. The use of syringes and medicines ensure healthy and long lives for pets.

Advancement in the technology has led to selection of animal health dosing syringes based on their size and treatment. Also increasing prevalence rate of diabetes in animals will increase the veterinary syringes market. However poorly injected products may not absorb properly in the body of animals and cause scar tissue, animal pain.

Also these veterinary syringes are inexpensive. To control diabetes successful therapy of insulin is required with accurate dosing which requires usage of veterinary syringes this is expected to further increase the demand for Veterinary Syringes. According to the American pet society approximately 1 in 300 adult dogs and 1 in 230 cats in the US are suffering from diabetes which will also drive the Veterinary Syringes market.

Regional Market Outlook Veterinary Syringes Market

Geographically, the Veterinary Syringes Market is segmented into various regions such as Europe, North America, Asia-Pacific, Latin America, Japan and Middle East & Africa. United States in North America is expected to dominate the Veterinary Syringes Market globally, followed by Europe, due to increasing adoption of companion animals in the region. Further, the availability of advanced products helps in managing the disease of the animals which is expected to boost the market Veterinary Syringes in the region. The veterinary syringes provide effective results for diabetes care which can increase the pet’s life.

The Veterinary Syringes Market in Asia Pacific is expected to grow at a higher rate due to adoption of animals which will increase the usage of Veterinary Syringes. In addition, countries such as India and China are expected to witness higher revenue growth during the forecast period.

Some of the major players in the Veterinary Syringes Market are Giordano Poultry Plast S.p.a., Hubert De backer nv, Intervet Inc., Nordson Corporation, Neogen Animal Safety, Becton, Dickinson and Company, genia, ThaMa-Vet Terumo Medical Corporation, SOL-Millennium, EXELINT among others. Moreover, the manufacturers and the producers are mainly focusing on strengthening the core competencies of their product portfolio.

Key data points covered in report

The report covers exhaustive analysis on:

  • Veterinary Syringes Market by Product Type, End Users and region type
  • Regional level market analysis of North America, Latin America, Europe, Asia Pacific, Middle East & Africa by Indications, End User and country segments
  • Veterinary Syringes Dynamics & Opportunity Assessment
  • Historical Actual Market Size, 2013 – 2017
  • Veterinary Syringes Market Size & Forecast 2018-2028
  • Veterinary Syringes Market Current Trends/Issues/Challenges
  • Competition & Companies involved in Veterinary Syringes Market

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-10238

Veterinary Syringes Market: Segmentation

Tentatively, Veterinary Syringes Market has been segmented on the basis of Product type, animal type, Dosage, End User and Geography.

Based on Product type, the Veterinary Syringes Market is segmented as:

  • Hypodermic Needles
  • Insulin syringes
  • Feeding and Specialty Syringes

Based on animal type, the Veterinary Syringes Market is segmented as:

  • Bovine animals
  • Equine animals
  • Companion Animals

Based on dosage, the Veterinary Syringes Market is segmented as:

  • Fixed Dosage
  • Variable dosage
  • Multi-purpose dosage

 Based on End User, the Veterinary Syringes Market is segmented as:

  • Veterinary Hospitals
  • Homecare centers
  • Veterinary clinics

Based on region, Veterinary Syringes Market is segmented as:

  • North America
  • Latin America
  • Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape, market structure, regulatory scenario
  • Epidemiology outlook for diseases
  • Economical spending, regional healthcare outlook, consumer healthcare expenditure
  • Availability of device, cost of the procedure, specificity and sensitivity
  • Strategies for key players in and product offerings, Channel strategies, regional foot print, channel footprint for Veterinary Syringes Market
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance in terms of value and volume

Heat Moisture Exchanger Market Expected to Witness High Growth by 2029

Heat moisture exchanger are intended for providing efficient recovery of heat and moisture. These heat moisture exchanger are intended to support minimized resistance to flowing air and produce high moisture to compensate loss of heat and moisture in patients with breathing and other respiratory problems. All heat moisture exchanger have standard tapered ends to assure leak free seal. The provision of warm and humid gas through heat moisture exchanger for patients in the intensive care units have been recognized as necessary and various methods for ensuring this functionality has been taken care by the device manufacturers.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-9668

Heat Moisture Exchanger: Market Dynamics

Generally, heat moisture exchanger are intended to provide a more secure airway respiration in patients who require mechanical ventilation or at risk of aspiration. The introduction of light and disposable heat moisture exchanger that effectively conserves moisture has been effective in improving patient care. Nowadays, combined form of heat moisture exchangers along with filters are being used which seem to have fulfilled major functions which are otherwise lost to the patient with an intubated trachea.

Over the years, geriatric population treatment, respiratory diseases, traumatic injuries and treatment have increased many folds resulting in increased demand for heat moisture exchanger. Furthermore, increase in conducting preventive therapeutic programs are anticipated to drive the growth of the heat moisture exchanger market. In contrary, stringent regulation policies in certain countries with respect to heat moisture exchanger’s price, safety and efficacy is anticipated to hinder the market growth. Use of alternative devices to heat moisture exchanger such as heated humidifiers may also affect the growth of the market.

Many studies have reported that increased airway hydration, by heated humidifiers may decrease incidence of bacterial infection whereas heat moisture exchanger humidifiers carry risks of airway occlusion. Usage of such alternative devices may significantly alter the market of heat moisture exchanger. Ongoing R&D activities related to heat moisture exchanger are anticipated to present new opportunities for growth of the heat moisture exchanger market.

Heat Moisture Exchanger Market: Overview

Ongoing R&D activities related to respiratory and tracheal devices are anticipated to present new opportunities for the heat moisture exchanger market. In competitive landscape, the heat moisture exchanger market comprises of both global and regional manufactures, thereby making the market highly competitive. To be leader in the market, the manufacturers of heat moisture exchanger have inculcated new strategies for expanding their product portfolio and footprint in the market. They are trying to develop innovative heat moisture exchanger products by investing aggressively in R&D and expanding product footprint in developing nations. Additionally, several key manufacturers of heat moisture exchanger are floating in huge investments to acquire or merge small and local companies.

Heat Moisture Exchanger Market: Region-wise Outlook

National Center for Health Statistics have reported that more than millions of surgical procedures of admitted inpatients are performed globally each year and more than half of them use heat moisture exchanger during intraoperative and postoperative respiratory support. On the basis of geography. North America is anticipated to be leader in global heat moisture exchanger market. Increase in geriatric population requiring surgical procedures by mode of airway ventilation through heat moisture exchanger will drive the regions market. Europe followed by Asia Pacific is expected to be next dominating region in global heat moisture exchanger market. Russia is anticipated to lead the market share of heat moisture exchanger market. Russia’s Health Ministry report of 2016 estimated a noticeable increase in the incidence rate of respiratory disease in Russian adults. The Asia Pacific countries such as China and India, are anticipated to grow at an exponential rate for the heat moisture exchanger during forecast period.

Heat Moisture Exchanger Market: Key Players

Some of the key players present in global heat moisture exchanger market include Biopsybell, King Systems, Vadi Medical, Toshiba Air Conditioning, Galemed, Draeger, Pharma Systems AB, Smiths Medical, Sarnova, Intersurgical, Medtronic Teleflex and others.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-9668

Heat Moisture Exchanger Market: Segmentation

Segmentation by Device Type:

  • Disposable Heat Moisture Exchanger
  • Reusable Heat Moisture Exchanger

Segmentation by Application Type:

  • Respiratory Care
  • Pediatric Care
  • Neonatal Care

Segmentation by End User Type:        

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance

Perfusion Imaging Market to Witness Stunning Growth by 2029

Perfusion imagining helps in identifying nutritive blood supply to an element of tissue. Perfusion imaging techniques have the capability to generate both perfusion measurements and perfusion maps of the region of interest. In the perfusion imaging market, the application of such imaging techniques have been growing over the years. The market growth is primarily due to need for perfusion imaging for evaluating key body functions via assessing a number of functional and metabolic parameters.

The various perfusion imaging tools available in the market ranges from microspheres to computed tomography. These product tools help in mapping the blood through the brain’s vascular network. The market of perfusion imaging is expected to have a healthy CAGR over the forecast period due to continuous product lunch and demand for novel techniques to non-invasively measure various hemodynamic parameters.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-9650

Perfusion Imaging: Market Dynamics

The perfusion imaging market is anticipated to increase in the forecast period. It is anticipated that the growing demand for non-invasive therapies and treatment will drive the market of perfusion imaging in the forecast period. Rise in number of cardiovascular diseases, brain tumours, tumour-related angiogenesis etc. is also expected to drive the market of perfusion imaging market.

According to WHO, globally one billion people every year suffer from either one or many type of neurological disorders. Amongst these 50 million account for epilepsy and allied diseases where as 24 million suffer from Alzheimer. Prolonged sickness in neurological disorders results in 6.8 million death.  However, fast processing of perfusion imaging systems and tools which takes 60-75 seconds of time to image the circulation of blood supply helps in patient’s treatment process immensely.

Other recent developments in perfusion imaging market include new radioactive material with shorter life span. It reduces exposure of the patient to radioactive material. However high treatment cost, expensive devices and poor hi-tech healthcare penetration in lower income regions will restraint the growth of the perfusion imaging market.

Perfusion Imaging Market: Overview

Measurement of tissue perfusion imaging primarily depends on the performance and concentration of tracer agent in the target organ of interest. Nowadays, new and exogenous tracers are being used in Perfusion Imaging which are equally effective with lesser side effects. These include chilled saline solution, radio nucleotides and iodinated radiographic contrast material. With recent developments in MR imaging, both exogenous and endogenous tracer agents have been extensively used in the perfusion imaging market

Perfusion Imaging Market: Region-wise Outlook

North America will account for the largest share in global perfusion imaging market. Presence of manufacturing site of some of the key perfusion imaging product manufacturers is expected to generate regions revenue. European regions owing to aggressive healthcare infrastructure will also be leading revenue generating market after North America for perfusion imaging. East and South Asian countries along with some of the Latin American countries are expected to be the fastest growing perfusion imaging market in the forecast period due to these regions advancements in healthcare facilities and rise in annual per capita income.

GCC countries from Middle East and African region are also expected to show decent growth but some poor countries from region will negatively impact the global perfusion imaging market growth. It is believed lack of training sessions for operating the systems is the main reason for region’s poor market growth for perfusion imaging.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-9650

Perfusion Imaging Market: Key Players

Some of the key players operating in global perfusion imaging market are GE Healthcare, Toshiba Medical System., Positron, Aetna Inc, NeuSoft, Bracco, Cigna, kmhlabs, Perimed AB., Siemens Health, Philips Healthcare, Lantheus Medical Cardiac Imaging Solutions Inc. and others.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Europe (Germany, Italy, France, U.K, Spain, Russia, Nordic countries, BENELUX, Rest of Europe)
  • East Asia (China, Japan and South Korea)
  • South Asia (India, Malaysia, Thailand, Indosneasia Rest if APEJ)
  • Oceania (Asutarlia and New Zealand)
  • The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Perfusion Imaging Market: Segmentation

Segmentation by Product Type:

  • Microspheres
  • Computed tomography (CT)
  • Magnetic resonance imaging (MRI)
  • Others

Segmentation by Application:

  • Ventilation Perfusion Imaging
  • Myocardial Perfusion Imaging
  • Functional Brain Imaging
  • Testicular Torsion Detection
  • Others

Segmentation by End User Type:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance

Lacrimal Duct Stent Tube Market to Witness a Healthy Growth by 2029

Introduction of upgraded and highly precise lacrimal duct stent tube for canalicular stenosis or obstruction and congenital nasolacrimal duct obstruction remains a key booster to the growth of lacrimal duct stent tube market. The global market for lacrimal duct stent tube is projected for a promising 6% CAGR during 2019 – 2029, as suggested by a new Future Market Insights (FMI) report.

There has been higher preference for bicanalicular lacrimal duct stent tube over its monocanalicular counterpart, attributing to the former’s high success rate, suitability for stenting in older patients, and better clinical outcomes. Moreover, increasing prevalence of retina-related conditions, primarily imperforation of nasolacrimal duct, epiphora both in infants and adults, and conditions necessitating dacryocystorhinostomy are other factors responsible for propelling revenue growth of the lacrimal duct stent tube market.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-9649

Consistent efforts towards diagnosis and management of lacrimal duct obstruction with enhanced success rate, minimally invasive lacrimal surgery, and better clinical outcomes, and increasing product awareness among ophthalmologist are factors augmenting growth prospects for the lacrimal duct stent tube market.

Key Takeaways – Lacrimal Duct Stent Tube Market Study

  • Bicanalicular lacrimal duct stent tube is expected to contribute three fourth of revenue share in the lacrimal duct stent tube market owing to its high success rate in stent placement.
  • Hospitals captured maximum share of the lacrimal duct stent tube market owing to highest patient footfall followed by ophthalmic clinics.
  • Attributed to growing patient pool for retinal diseases, especially due to premature births, contributed to the dominance of North America in the lacrimal duct stent tube market.
  • Increasing awareness for availability of the treatment for nasolacrimal duct stent obstruction among caregivers of prematurely born babies and increasing number of skilled professionals are expected to drive growth of the lacrimal duct stent tube market in East Asia.
lacrimal duct stent tube market share by region

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-9649

Manufacturers Emphasizing Advanced Product Development

Numerous organizations are focusing on new product development for lacrimal duct stent tube. In June 2019, FCI Ophthalmic offered a complete line of BIKA stents namely, BIKA, BIKA for DCR, and Infant BIKA covering a range of sizes that will benefit most of the congenital nasolacrimal duct obstruction (CNLDO) and dacryocystorhinostomy (DCR) cases.